Your browser doesn't support javascript.
loading
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study.
Ip, Cheng-Teng; Olbrich, Sebastian; Ganz, Melanie; Ozenne, Brice; Köhler-Forsberg, Kristin; Dam, Vibeke H; Beniczky, Sándor; Jørgensen, Martin B; Frokjaer, Vibe G; Søgaard, Birgitte; Christensen, Søren R; Knudsen, Gitte M.
Afiliação
  • Ip CT; Department of Clinical Pharmacology, H. Lundbeck A/S, Valby, Denmark; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Olbrich S; Department of Psychiatry, Psychotherapy and Psychosomatic, University Zürich, Switzerland.
  • Ganz M; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Computer Science, University of Copenhagen, Copenhagen, Denmark.
  • Ozenne B; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Section of Biostatistics, Department of Public Health, University of Copenhagen, Denmark.
  • Köhler-Forsberg K; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dam VH; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Beniczky S; Department of Clinical Neurophysiology, Danish Epilepsy Center, Dianalund, Denmark; Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark; Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.
  • Jørgensen MB; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Psychiatry, Psychiatric Centre Copenhagen, Copenhagen, Denmark.
  • Frokjaer VG; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Søgaard B; Department of Clinical Pharmacology, H. Lundbeck A/S, Valby, Denmark.
  • Christensen SR; Department of Clinical Pharmacology, H. Lundbeck A/S, Valby, Denmark.
  • Knudsen GM; Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: gmk@nru.dk.
Eur Neuropsychopharmacol ; 49: 101-112, 2021 08.
Article em En | MEDLINE | ID: mdl-33910154

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur Neuropsychopharmacol Assunto da revista: PSICOFARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur Neuropsychopharmacol Assunto da revista: PSICOFARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca